December 21, 2016
Nippon Shinyaku said on December 19 that it has obtained exclusive rights in Japan to develop and commercialize Monofer (iron isomaltoside 1000), a treatment for iron deficiency developed by Denmark’s Pharmacosmos A/S. Monofer is already available in more than 34...read more